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 The suture is one of the most commonly used medical devices, consisting of a 
fiber, a surgical needle and the packaging in which it is stored.  The fiber itself remains 
after implantation for a defined time and  is responsible for the approximation of the 
wound during the healing process.  The needle merely serves to aid in insertion, and 
preferably has a diameter larger than the diameter of the fiber . 
            The 1970’s marked the birth of a new family of fibrous materials for the 
approximation of wounds: synthetic absorbable sutures.  This family has the ability to 
provide wound support during the early stages of wound healing, but also possesses the 
ability to fully absorb over time.  This reduces the incidence of complications that can be 
caused by the permanent presence of a foreign body.   
            Currently, there are issues regarding the ability of the wound site to achieve 
hemostasis, due to holes created by the needle that are not completely filled by the 
suture.  This blood leakage can lead to significant hemorrhaging and, in the case of 
gastrointestinal surgeries, can lead to contamination and bacterial growth.  The aim of 
this research is to create a suture that is inserted with a diameter smaller than that of the 
needle, but that increases in diameter after implantation to partially or fully fill this 
hole.  To achieve this end, a new amphiphilic suture line comprising polyethylene glycol 
and a lactone monomer base (L-lactide, 1,4-dioxan-2-one) was investigated.  This work 
concluded with the selection of a quickly absorbing polymer composition that has 
strength and long lasting strength retention comparable to commercially available 
absorbable surgical sutures, but with the added ability to swell upon implantation.  The 
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Early Usage of Fibers for Wound Closure 
Physicians have been using fibers to approximate wounds for at least 4000 years.  
Archaeological records show that linen, animal sinew, grass, cotton, animal gut, flax, 
animal gut and silk were all used by the ancient Egyptians and East Indians to repair 
wounds.  As early as 131 AD, the Greek physician Claudius Galen described early forms 
of the modern gut fiber used as sutures and, in approximately 300 AD, Greek surgeon 
Antyllus used this material to perform bone and joint resections as well as tracheotomies 
and repair of traumatic aneurysms.  In the 1500’s, a French barber by the name of 
Ambroise Paré, who eventually became a notable surgeon, used linen strips and silk for 
vascular ligature repair  [1].  In the 1800’s, buckskin and silverwire were first introduced.  
In 1860, Joseph Lister, a British physician, developed gut sterilization techniques using 
carbolic acid and, in 1880, he introduced a chromic acid salt-treated form of gut fiber that 
actually had double the strength retention of plain gut suture.  By the 1900’s, the German 
biomedical industry was using sausage rapping materials derived from sheep intestines to 
mass produce gut suture. 
The Suture 
The suture is one of the most commonly used medical devices and comprises a 
fiber, a surgical needle, and the packaging in which the fiber and needle are stored.  Upon 
implantation, the fiber is the only part of this device that remains in place.  As such, the 
design of this fiber material is not just critical for the immediate approximation, but also 
for the extended wound healing process.  The needle is attached to aid insertion while the 
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packaging serves to preserve a dry, sterile environment for the suture prior to use [2].  In 
order to address complications commonly associated with suture materials, as well as 
improve the efficiency of the modern operating room, long overdue improvements to 
modern suture design must be implemented. 
In the 1900s, synthetic polymers began to become more prevalent; polyvinyl 
alcohol was the first of these synthetic materials. However, with the advent of 
polyglycolide in 1970, a new family of synthetic polymers arose that had the unique 
ability to degrade by hydrolysis, as opposed to by attack by the body’s immune system.  
Following this genesis, more polymers were developed using other cyclic ester 
monomers as a base, sometimes augmenting these polymers with a carbonate monomer 
known as trimethylene carbonate.  These synthetic polymers comprise one or more of the 
following monomers:  glycolide (GLY), d-lactide, l-lactide (LLAC), 1,4 Dioxan-2-one 
(PDO), trimethylene carbonate (TMC), ε-caprolactone, and vinyl alcohol [2].  Table 1 
gives a chronological summary of the advent of these materials.  [1] 
  Table 1.  Chronological Arrival of Synthetic Suture Materials 
Year Base Suture Material 
1931 Polyvinyl Alcohol, “PVA” 
1970 Polyglycolide, “PGA” 
1974 Polyglycolide, “PGA” 
1974 Poly(glycolide-co-l-lactide), “PGLA” 
1981 Polydioxanone, “Poly-PDO” 
1984 Poly(glycolide-co-trimethylene carbonate), “Polyglyconate” 
1992 Poly(glycolide-co-ε-caprolactone) “Polyglecaprone”  







A biomaterial is any natural or synthetic substance that interacts with a biological 
system.  Accordingly, a biomaterial may be designed to facilitate medical treatment.  
Typical biomaterials are metals, ceramics, glasses, or polymers.  Polymers possess great 
potential, due to their diverse range of physical and mechanical properties; these 
biomaterials may be varied by modifying their composition, molecular weight, and 
structure.  Polymers can even be designed to degrade controllably to allow complete 
absorption without further medical intervention.   
In order to be suitable for use, absorbable materials must not invoke a sustained 
inflammatory response, must maintain desirable properties long enough to serve their 
function, must degrade into products that can be absorbed and ultimately excreted 
without excessive toxicity, and must be processable to fit the desired application.  Factors 
that may affect these properties include chemistry, molecular weight, level of 
hydrophilicity, surface charge, water intake, rate of degradation, and the toxicity of 
erosion products resulting from the degradation of these degradable polymers.   
 Hydrolytically degradable polymers are of particular interest in wound closure.  
These polymers can be broken down, independent of the body’s inflammatory/immune 
response, by hydrolytic degradation of their chemical bonds.  Bonds susceptible to 
hydrolysis include esters, anhydrides, carbonates, amides, phosphates, urethanes, and 
acetals.  Degradation rates and erosion mechanisms must be understood when using these 
materials.  Degradation rates vary between rapidly degrading phosphazenes and more 
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hydrolytically stable polyamides.  Device geometry and water diffusion can also 
dramatically affect that rate at which a degradable polymeric biomaterial can erode.   
Degradation can either take place by surface erosion, bulk erosion, or a 
combination of both.  Surface erosion takes place when the degradation and mass 
absorption at the water-polymer interface exceeds the water diffusion into the device.  
This leads to erosion primarily at the polymer surface.  Bulk erosion occurs when water 
diffuses into the material fast enough to cause uniform degradation throughout the 
polymeric device [3].  This can however, lead to degradation of material toward the 
center of the device, leading to a rapid release of degradation bi-products should the outer 
shell breach. 
Suture Materials 
 All suture materials fall into two categories:  absorbable (ABS) or non-absorbable 
(NA).  Within these two categories are three types of materials:  natural unmodified, 
natural modified, and synthetic. 
 Nylon, polypropylene, silk, steel, and cotton are examples of NA sutures, while 
ABS sutures comprise natural or synthetic materials.  Most commercially available ABS 
sutures lose at least 50% of their strength within 4 weeks; however recent technological 
advances have resulted in lactide-based ABS sutures that can maintain a significant 
amount of strength for up to 2 months.  Strength retention typically comes with the 
drawback that it takes months to years for many ABS sutures to fully absorb, since 
strength loss is considerably faster than mass loss.    
5 
 
 Examples of modified natural sutures are plain gut and chromic gut, which are 
both collagen-derived sutures.  Plain gut and chromic gut were the first degradable 
materials to be used and are still in use today.  Gut sutures are primarily composed of 
material derived from bovine intestinal serosa, but are also sometimes derived from the 
submucosa of sheep or goat intestines.  The primary material in gut suture is collagen but, 
because it is animal based, it must be purified of antigenic elements such as proteins.  
After processing the animal matter, this biomaterial is cut into ribbons and then treated 
with formaldehyde, which increases its strength to more acceptable levels and slows the 
degradation rate, leading to prolonged strength (having a load that is effective for 
approximately 7 days for plain gut and 14 days for chromic gut) [4].  These ribbons are 
twisted together and processed further to arrive at the final diameter.  After the initial 
processing, chromic gut is processed further by tanning in the presence of chromium 
salts.  Plain gut maintains usable strength for approximately 1 week and chromic gut 
maintains its strength for approximately 2 weeks.  Despite the attempts to remove 
antigenic matter, gut suture is known to have high tissue reactivity [5].  This material is 
used on fewer occasions due to its short effective strength retention, low knot security, 
high cost to produce, high tissue reactivity, and due to increased concern about 
Creutzfield-Jacob Disease (Mad Cow Disease) [4]. 
Homopolymers of glycolide, 1,4 Dioxan-2-one, l-lactide, and ε-caprolactone 
degrade/lose strength from fastest to slowest in the order as listed.  These polymers are all 
in the family of poly(α-esters) and possess hydrolysable aliphatic ester bonds in their 
backbones.  Polyglycolide is a strong/stiff polymer that, when fashioned into a suture, has 
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good knot security and quick absorption characteristics.  This quick degradation, 
however, means that it retains its strength for a shorter period of time while rapidly 
releasing high levels of glycolic acid, which sometimes leads to an undesirable 
inflammatory response.   
The steric hindrance of the methyl group in polylactide slows the rate of 
hydrolysis.  For example, a polylactide homopolymer would have a slower loss of 
strength and a longer time of residence in vivo than a glycolide homopolymer, which is 
similar in structure to lactide, but lacking the steric hindrance of the methyl group.  This 
slower degradation results in a slower release of degradation byproducts.  Polylactide 
suture material, however, can take over five years to be absorbed by the body.  Like 
polyglycolide, poly(l-lactide) is relatively stiff, has good strength, and has good knot 
security [4].   
Polydioxanone is a homopolymer of 1,4 dioxan-2-one and is softer than both 
polylactide and polyglycolide.  PDO sutures generally have strength retention and 
degradation profiles that are intermediate to those of polylactide and polyglycolide.  
TMC and ε-caprolactone are mainly used as modifiers rather than as primary monomers 
in homopolymers/copolymers and are usually only used to modify mechanical properties 
of the other poly(α-esters) [2].  Indications, compositions, and absorption characteristics 







Table 2. Suture Compositions, Indications, and Absorption/Strength Retention Properties    
Suture
A





m Time to Full 
Resorption 
Gut Collagen 
General soft tissue approximation 
and/or ligation, but not for use in 
cardiovascular or neurological 
tissues, microsurgery, or ophthalmic 
surgery 
















5 Days 5% 
10 Days 25% 








7 Days 50-60% 





Soft tissue approximation and/or 
ligation including use in ophthalmic 
procedures, but not in cardiovascular 
or in neural tissue 
2 Weeks 65% 
3 Weeks 35% 






All types of soft tissue 
approximation, including use in 
pediatric cardiovascular, tissue 
where growth is expected to occur, 
and opthalmic surgery. PDS II 
suture is not indicated in adult 
cardiovascular tissue, microsurgery 
and neural tissue.  These sutures are 
particularly useful where the 
combination of an absorbable suture 
and extended wound support (up to 
6 weeks) is desirable. 
2 Weeks 70% 
4 Weeks 50% 
6 Weeks 25% 
/< 6 Months[10] 
A 
Gut and chromic gut are manufactured by Covidien and Ethicon.  BSR values and resorption 




are Covidien products.  
Monocryl
TM
 and PDS II
TM
 are produced by Ethicon.  
 B
Gut suture degradation is primarily due to 






 Suture fabrication is accomplished either by melt extrusion, gel-spinning, or by 
forming natural materials into fibers.  A drawing process may follow extrusion, where the 
fiber is heated and polymer chains are aligned to orient the amorphous regions and 
crystalline regions axially, thereby increasing the strength of the fiber.  To create 
multifilament sutures, small diameter fibers are combined by braiding and are then 
stretched to tighten the construction of the suture, further increasing the strength of the 
suture.  Monofilament and multifilament sutures are often processed further by annealing 
and relaxing the suture to increase the strength and dimensional stability of the suture.  
The surface characteristics are then frequently modified by adding a coating to change 
the frictional characteristics, decrease the reactivity with tissue, improve the knot quality, 
or to control the release of a drug, such as an antimicrobial agent.   
Geometrical Variations for Sutures 
 Suture type and size is chosen based on factors such as the surgical site as well as 
the patient’s immune history, age, weight, health, and historical response to sutures.  
Suture size is based on the diameter of the suture strand, which is defined by the United 
States Pharmacopoeia (USP) [11].  Multifilament sutures are constructed of braided 
filaments; typically, materials used in multifilament sutures have a relatively high 
Young’s Modulus, making them less suitable for monofilament application; however, 
despite the higher material stiffness, the ease of use, or “hand”, of multifilament sutures 
is perceived to be much better, resulting in fewer throws being necessary for a secure 
knot.  Because of the braided nature of multifilament sutures, the suture strength is less 
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susceptible to damage caused by handling.  Unfortunately, braided sutures have distinctly 
greater surface area than monofilament sutures, which makes braided sutures more 
susceptible than monofilament sutures to bacterial colonization.  Furthermore, the higher 
surface area of multifilament sutures results in higher tissue friction, meaning that more 
tissue trauma occurs upon entry into the wound area.  For this reason, braided sutures are 
usually coated.  
Needles 
In order to minimize drag, the needle diameter and its relationship to the diameter 
of the fiber.  To minimize drag, the needle diameter should be larger than the fiber to 
which it is attached.  Modern needles are typically swaged.  Drilled swaging, used for 
larger size needles, is accomplished by drilling a hole into the distal end of the needle and 
using an adhesive to hold the suture in place.  Recent advances in laser-drilled swaging 
techniques have reduced the necessary needle wire diameter for a given size suture.   
Mechanisms of Suture Absorption and the Wound Healing Process 
 Neutrophil proteolysis, an immune response is the primary degradation 
mechanism for collagen-based sutures, inherently causing them to be more reactive than 
other types of absorbable sutures.  This reactivity can lead to scarring.  Hydrolysis, or 
degradation by water, is the primary degradation mechanism for synthetic sutures, which 
causes them to be less reactive.  
 The three major stages of wound repair are inflammation, cell proliferation, and 
remodeling.  The initial response to a breach in the skin’s integrity is the appearance of 
platelets, causing hemostasis through fibrin clot formation and also signaling 
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macrophages and fibroblasts to migrate to the site of injury.  The recruitment of 
neutrophils, lymphocytes, and macrophages marks the beginning of the inflammatory 
process.  The proliferative phase significantly overlaps the inflammatory phase, resulting 
in the formation of the epithelium by cells migrating across a provisional matrix.  The 
proliferative phase also results in the formation of blood vessels, collagen deposition, and 
formation of extracellular matrix.  Remodeling of the collagen follows the proliferative 
phase, as does regression and vascular maturation, with the entire phase lasting 6-24 
months from the time of injury for humans [12]. 
The Inflammatory Phase and Scar Formation 
 The early inflammatory phase, which begins within minutes of injury, has a large 
influence on the areas of scar formation.  Migration of neutrophils and macrophages is 
stimulated by growth factors and cytokines.  Metalloproteinases and collagenases, 
released by neutrophils as well as macrophages, begin to break down tissue with free 
radicals, resulting in a void that is ultimately filled with scar tissue.  One study, using a 
PU.1 null mouse, a type lacking macrophages and neutrophils, showed incisional and 
excisional wound healing rates that were statistically not different from those of wild type 
rats, but showing no scar formation.  Cell death was even reduced, due to differences in 
the cytokine and growth factor profiles for the PU.1 null mouse, coincident with the lack 
of scar formation.  Other studies centered around platelets and mast cells showed that 
these mediators are not essential to effective wound repair.  These studies suggest that 





 It has been shown that hydrophilic surfaces encourage greater cell attachment 
than hydrophobic surfaces [13].  Surface wettability, a parameter that can be measured by 
surface contact angle, reflects the distribution of surface-free energies on the implant 
surface.  Hydrophilic surfaces tend to have alternating surface polarities, as opposed to 
hydrophobic surfaces, which behave neutrally.  It has been further demonstrated in vitro 
that surface-free energy and electric field have a marked ability to affect cell adhesion 
and growth.  This occurence is believed to be due to the binding of cationic amino acids 
and proteins as well as inorganic cations to a more negatively charged implant, making 
the implant more attractive to a cell membrane, which is negatively charged.  In a study 
conducted by Kloss and coworkers, titanium discs with coatings of varying hydrophilicity 
were implanted under the subdermal soft tissue layer of the abdominal skin of 24 Wistar 
rats.  The rats were euthanized/evaluated after 1 and 4 weeks (12 rats per time-point).  
The fibrous layer and soft tissue were stained and evaluated at each time-point, and it was 
observed that the vascularization and cell number were significantly increased for the 
tissue-implant interface with the more hydrophilic discs (i.e. the surface with the lower 
contact angle).    
The Cells Involved in Wound Healing 
 Wound healing is centered around a tissues’s own damaged or lost cells, which 
are usually terminally differentiated.  In myocardial tissue, and other non-dividing 
tissues, lost cells are never replaced, but in other tissues, such as continuously dividing 
tissues, cells are constantly being lost and replaced throughout a lifetime.  This 
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regenerative capacity lies in stem cells deep within the tissue.  Stem cells are unique in 
that they have the ability to self-renew and the capacity to differentiate into multiple cell 
types.  The two types of self-renewal are symmetric replication and asymmetric 
replication.  In the former case, a stem cell differentiates into two daughter stem cells, 
also self-renewable, while in the later case, one daughter cell remains self-renewing while 
the other continues differentiating.   
Embryonic stem cells, a type of pluripotent stem cells, can differentiate into any 
type of cell.  Adult (or somatic) stem cells are multipotent, so are limited to a narrower 
range of differentiation pathways and, therefore, cells.  Adult stem cells are found in most 
tissues in the body, including the gastrointestinal epithelial lining, cornea, continuously 
dividing tissue (e.g. skin), hematopoietic tissue, adipose tissue, liver, and pancreas.  
Despite the longtime belief that cells in the central nervous system do not proliferate, 
stem cells are sometimes even found there.   
 Stem cells typically reside in micro-environments within a tissue that are made up 
of both stem cells and non-stem cells.  The stem cells are stimulated by neighboring non-
stem cells to divide when necessary.  This signaling causes a stem cell to divide more 
rapidly than it would on its own.   
 Other cells instrumental in wound healing include fibroblasts, macrophages, and 
endothelial cells.  Healing of wounded tissue to its original state is usually impossible; 
hence, fibroblasts, driven by growth factors and cytokines, are necessary to replace the 
region of lost cells with an acellular collagenous tissue.  Macrophages, in addition to 
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digesting foreign matter, release fibroblast-stimulating growth factors as well as 
keratinocyates and endothelial precursors [14]. 
Hemostasis of Needle Hole Bleeding 
In a study comparing the use of fibrin glue (FG) to thrombin-soaked gelatin 
sponges as needle hole sealants, FG was shown to be more effective in achieving 
hemostasis of needle hole bleeding, but risk of infection due to the use of these naturally-
derived substances could not be ruled out [15].  In the case of gastrointestinal surgeries, 
anastomoses can be contaminated, and FG promotes bacterial growth, leading to elevated 
risk of infection.  Therefore, a clinically relevant solution to this issue has not been found 
to date [15]. 
 Bioswellable sutures were designed to lessen the disparity between the suture 
cross-section and that of the needle, in order to mitigate blood loss through the needle 
hole, resulting in lower amounts of blood loss and a lower incidence of infection.  This 
approach is potentially useful to colorectal, cardiovascular, and laparoscopic surgery 
[15]. 
 In most cases, due to limitations in manufacturing processes, the needle diameter 
far exceeds that of the suture it is guiding, manifesting in a needle-to-suture cross-
sectional ratio that can be as high as 2:1 or 3:1, resulting in blood leakage and increased 
potential for infection [14].  A study was conducted by Miller and coworkers in 1987, in 
which polypropylene sutures were used to augment a 6mm polytetrafluoroethylene 
(PTFE) graft interposed in an end-to-end fashion in the infrarenal canine aorta (total of 82 
canines).  In this study, anastomotic bleeding was reduced from 33.4mL to 4.3mL per 
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anastomosis when a suture:needle cross-sectional area ratio of 1.00:1.00 was used instead 
of 1.94:1.00 (Total n=82).  The conclusion of this study was that use of a needle-to-suture 
ratio of 1:1 greatly reduced graft needle hole bleeding [15]. 
Scar Formation and Return to Function 
 Hematomas, which result from ongoing bleeding, create excessive extrudate and 
are powerful stimuli in the formation of scarring.  Infection is a condition that can cause 
secondary inflammation, breaking up pre-existing scar tissue, leading to additional 
collagen deposition, and ultimately leading to additional formation of scar tissue.  The 
synthesis-lysis mechanisms are balanced in a healthy adult, under ordinary conditions.  
Injury-induced inflammation, however, causes a hormonal stimulation for the enzyme 
collagenase, a pervasive enzyme typically found in rheumatoid synovial cells and post-
partum uterine tissue.  Collagenase activity is highest at the site of injury.  Infection is a 
condition that causes secondary inflammation, which in turn leads to the additional 
resorption and synthesis of collagen, and ultimately additional scar formation.  Therefore, 
it is believed that conditions providing a reduction in hematoma formation and reduced 
chance for infection will restore tissue to back to full function more quickly [16]. 
Sutures and Grafts 
Peripheral vascular and colorectal anastomoses are complicated by the need for 
graft suturing as well as direct suturing.  Because of a risk of infection in the intestinal 
area as well as a high potential for blood loss in vascular applications, monofilament 
sutures are used for these purposes.  While only indicated for use in pediatric 
cardiovascular applications, PDS II and Maxon, which both maintain at least 25% of their 
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initial strength for up to 6 weeks, are among the few absorbable sutures approved for 
cardiovascular use at all (Manufacturers “Instructions for Use”).   
In one study, end-to-end anastomoses were performed in the iliac arteries of 
growing pigs using both non-absorbable polypropylene (Prolene) suture and absorbable 
polydioxanone (PDS) suture.  PDS was shown to be superior to Prolene because of a 
much lower inflammatory response, and a much lower blood loss through the needle-
holes (6.1±4.7 ml/min/100gm for PDS vs. 16.8±2.3 ml/min/100gm for Prolene).  The 
conclusion of the study was that PDS was clearly superior to Prolene for this application 
[17].  Another swine study compared the newer PDS II to Prolene.  The results of this 
study showed full absorption of the PDS II, a lower inflammatory response to the PDS II, 
and equivalent vascularization.  It was noticed, though, that thrombus formation occurred 
in one sample where PDS II was used, so the possibility of aneurysm formation must be 
considered when using PDS II for an anastomosis [1]. 
In addition to minimizing blood leakage, a suture must maintain sufficient 
strength for approximating a wounded tissue closure.  The wound closure is 
accomplished within 10-14 days, but the remodeling phase for tissue can last several 
months, so the suture must maintain sufficient strength for the risk of wound dehiscence 
to pass. 
Current suture methods for securing a graft during anastomoses are imperfect, due 
to the needle hole which is left by a larger diameter needle; therefore, it is often necessary 
to supplement these needle holes with a sealant to prevent blood loss and infection.  One 
method of preventing bleeding along the suture line is to apply a hemostatic aid such as 
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oxidized cellulose, bovine collagen, and gelatin, which all provide a mechanical scaffold 
on which autogenous thrombus will form.  Another method is to apply topical thrombin 
or a fibrin sealant, which involves mixing two separate solutions containing fibrinogen 
and thombin, thereby forming a clot.  Despite the ability of these agents to form clots, the 




 Surgical Adhesive (CryoLife, Inc.) is a product containing 
glutaraldehyde and bovine serum, which are mixed immediately upon application using a 
static mixing device.  Albumin and amine groups within the tissue react with the 
glutaraldehyde, resulting in rapid polymerization and reaching full strength in 2-3 
minutes.  While the ability of BioGlue
TM
 to achieve hemostasis has its advantages, 
BioGlue
TM
 does create some safety concerns due to the damage it causes to exposed 
nerves and cardiac conduction tissue, as well as due to its ability to leak into the 
bloodstream through needle holes.  In addition to its capacity for leaking through the 
anastomoses, BioGlue
TM
 is also problematic due to the potential of polymerized pieces to 
undergo secondary mobilization and enter the blood stream.  These particles, infamously 
known as “BioGlue
TM
 Bullets” present a serious stroke risk [3].  
Cyanoacrylate adhesives are also used at the tissue-graft juncture, both as needle-
hole fillers and stand-alone fixation devices.  Commercial cyanoacrylates, particularly N-
butyl-2-cyanoacrylate, act quickly to achieve hemostasis, especially in the treatment of 
arteriovenous shunts and femoral bypass procedures.  However, a study performed using 
Sprague-Dawley rats demonstrated that when an anastomosis was sutured with 
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polypropylene and no sealant, the burst strength was 168±58 mmHg, but when 
Histoacryl® N-butyl-2-cyanoacrylate was added as a sealant, the burst strength dropped 
to 60±38 mmHg.  This is possibly due to tissue damage and subsequent tissue strength 
loss that is caused by heat released by the exothermic reaction necessary for 
cyanoacrylate to approximate.  Additionally, there are toxicity concerns, and sealant entry 
into the wound can impede healing.   
Statement of Purpose and Research Plan 
The ideal suture possesses high tensile strength, is easy to use, triggers a low 
tissue reaction, and absorbs relatively quickly, while also providing adequate strength 
retention for the task at hand.  Also, a suture system with a needle diameter that is larger 
than the suture and that is able to achieve quick hemostasis of needle-hole bleeding is 
desired.  Such a perfect suture system should have a high needle-to-suture ratio when 
inserted, but have a low needle-to-suture ratio when healing is initially commencing.   
It is believed that a swellable material can be achieved through implementation of 
a family of polymers known as synthetically-derived polyethers.  This family of water 
soluble, highly biocompatible polymers has been used extensively in tissue and drug 
delivery applications for over 30 years.  Polyethylene glycol (PEG) is a particular 
polyether of interest due to its high ratio of water uptake ability to unit weight, while 
copolymers of ethylene glycol and propylene glycol are also of interest because of their 
intermediate levels of hydrophilicity.   
The focus of this research is to implement these polyethers into poly(α-ester) 
based chains to increase their hydrophilicity, which will allow them to swell, and in turn 
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swell to fill the needle holes, to be inductive to cell in-growth, and to increasingly 
encourage absorption with time through their ability to draw water closer.  This thesis 
describes attempts to form hydroswellable, load-supporting polymers that maintain their 





















MATERIALS AND METHODS 
Raw Materials 
The primary components of all of the reactions involved in this study consist of 
the α-ester family of monomers initiated by polyether diols.  Glycolide (G) and 
trimethylene carbonate (TMC) were purchased from B.I. Chemicals.  The ε-caprolactone 
(CL) was purchased from Acros Organic. Polyethylene glycol (PEG) of two different 
molecular weights, 20 and 35 kDa, were purchased from Sigma Aldrich.  A random 
copolymer with a molecular weight of 12 kDa, composed of 75 weight % ethylene glycol 
and 25 weight % propylene glycol (PRP) was purchased from Sigma-Aldrich Chemicals, 
l-Lactide (L) was purchased from Purac, 1,4 dioxan-2-one (PDO) was purchased from 
Medichem, and tin (II) 2-ethylhexanoate (SnOct) was purchased from Alpha Aesar.  
These materials are summarized in Table 3. 
Table 3.  Chemical Reagents 
Chemical Name Supplier CAS #  
(Unless Noted Otherwise) 










Trimethylene Carbonate (TMC) BI Chemical 2453-03-4 
1,4-Dioxan-2-one (PDO) Medichem 3041-16-5 
Glycolide (G) BI Chemical 502-97-6 
L-Lactide (L) Purac 4511-42-6 








 All reactions were performed under positive nitrogen pressure in a 1L stainless 
steel kettle/stirrer, equipped with a three-neck glass lid, a PTFE gasket at the interface of 
the lid/kettle, a PTFE bearing/glass adapter, a penny-head stopper, and a 90° adapter with 
a shut-off valve, shown in Figure 1.  Prior to reaction, the initiator (PEG or PRP) was 
dried in the kettle under vacuum with the PTFE bearing/glass adapter absent and replaced 
with glass straight adaptors terminated with a 90° adapter/shut-off valve, in order to 
completely seal the reaction setup and achieve an absolution pressure < 0.500 torr.   
 
 




A vacuum pump (Welch Duoseal® Belt-Drive High Vacuum Pump or an 
equivalent model) was used to apply vacuum.  Heat to the kettle was supplied indirectly 
by heated oil (Ace Glass High Temperature Silicone Bath Oil) in a steel reservoir.  A 
resistance heater, powered by a 1400W temperature controller, was used to heat the oil.  
Positive nitrogen pressure was regulated using an Ace Glass Firestone® valve.  The 
vacuum line was routed through this valve as well, allowing simple alternation between 
positive nitrogen pressure and vacuum. 
Copolymer Synthesis 
The polymeric initiators, PEG, were dried under vacuum (< 0.500 torr) at 110-
140°C.  High molecular weight, fiber-forming, crystalline, amphiphilic copolymers were 
prepared by end-grafting the polymeric initiator under positive nitrogen pressure with one 
or more of the following cyclic monomers: l-lactide, glycolide, trimethylene carbonate, ε-
caprolactone, and PDO.  Polymers were made using PEG with a molecular weight of 
20,000 g/mol or 35,000 g/mol to evaluate the impact of molecular weight for polymers 
with the same weight percent PEG.   
Polymer Grinding and Monomer Removal 
Following polymer synthesis, the polymers were cryogenically cooled with liquid 
nitrogen to assist with particle size reduction.  In this cooled state, an aluminum shaft was 
struck with a hammer to remove the polymer from the reaction kettle.  Once removed, 
using a hammer and chisel, the polymer was broken into pieces approximately 1.5 inches 
or smaller, immersing the polymer in liquid nitrogen as necessary to keep the polymer 
brittle.  The polymer was placed back into the liquid nitrogen to thermally equilibrate.  
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These polymer pieces were fed into a Thomas Model 4 Wiley® Mill to mechanically mill 
them into granules, assuring that the granules were less than 6mm in size, using a 6mm 
sieve at the exit of the grinder.  Upon exit from the grinder and the 6mm sieve, the 
polymer was mechanically sieved to remove particles smaller than 1000 µm.   
After sieving, the particles greater than 1000 µm were transferred to a 2000 mL 
glass recovery flask, then heated under reduced pressure (<0.500 torr) at elevated 
temperatures using a Buchi Rotovapor R-200 rotary evaporator to remove unreacted 
constituents (also referred to as devolatilization, DV).  A typical heating scheme for the 
lactide-based polymers consisted of 40°C for 4 hours, 80°C for 2 hours, and 110°C for 
3.5 hours.  The collection flask was cooled with liquid nitrogen, thereby encouraging 
condensation of vaporized monomer as well as maintaining a low vapor pressure within 
the vacuum setup.  Because of the lower melt typical for polydioxanone copolymers, it 
was necessary to lower the maximum temperature for PDO-based polymers, resulting in 
a typical heating scheme for those polymers of 40°C for 4 hours and 80°C for 6 hours.  In 
addition to the liquid nitrogen cooling of the collection flask, a coiled glass tube inside 
the condensation chamber was circulated with ice water (~4°C) at a rate of approximately 
0.5 gallons/minute, using a submersible pump to drive the flow. 
Fiber Formation 
 Fiber was extruded using an Alex James and Associates custom made ¾” screw 
melt extruder, with 4 heating zones, a 0.584 Zenith Metering Pump, and a 60 mil round 
hole dye. Extrudate was cooled with ice water and collected on a spool.  The fiber was 
then drawn to final diameter using custom heated godets with two heating zones, 
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orienting the polymer chains as well (approximately 75°C for the first zone and 85°C for 
the second).  The fiber was then annealed at 60-70°C while loosely wound on an 
aluminum rack placed in an oven.  This annealing process was to increase the 
crystallinity/strength as well as relieve residual stresses.   
Material for testing included sterilized and non-sterilized samples.  Sterilized 
samples were stored in foil pouches with a tyvec portion allowing gas transfer, and were 
sterilized using ethylene oxide, then sealed in such a manner that the fiber was sealed on 
all sides by foil.   
General Polymer/Fiber Characterization 
Thermal Properties 
The thermal properties were evaluated using a Perkin Elmer DSC6 Digital 
Scanning Calorimeter (DSC).  Samples weighing 5-10mg were placed into aluminum test 
pans on a microbalance, then the lid was placed onto the sample and crimped on using a 
special crimping tool.  The polymer was then heated in an inert gas (N2g) environment at 
a rate of 20°C/min, measuring the energy input differences between the sample pan and 
an identical but empty reference pan heated at the same temperature rate.  Melt 
temperatures, heat of fusion, and glass transition temperatures were measured in this 
manner. 
Nuclear Magnetic Resonance (NMR) 
A Jeol 300 ECX spectrophotometer was used to perform proton NMR (H
`
) on the 
samples, dissolved at a 1 wt% concentration in either deuterium substituted chloroform 
(CDCl3) or deuterium substituted hexafluro-2-propanol (HFIP-D2).  From the resulting 
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spectrum and knowledge of the types of molecules possibly present, the final 
composition of the polymer was determined.  In addition, unreacted constituent 
monomers were detected using this means. 
Gel Permeation Chromatography 
Molecular weight was determined by gel permeation chromatography (GPC) 
using Waters Styragel® columns and a Waters 2414 refractive index detector, with 
dichloromethane (DCM) as the mobile phase.  GPC is a size exclusion technique that 
separates a polymeric sample dissolved in a solvent according to molecular volume.  
Using this molecular volume, the number average molecular weight (Mn), the weight 
average molecular weight (Mw), and the polydispersity index (PDI) were determined.  Mn 
is largely determined by the monomer to initiator ratio of the polymer (M/I) and is 
strongly affected by the presence of lower molecular weight chains, due to their higher 
number given the same mass as chains of higher molecular weight.  Mw is more strongly 
affected by larger chains, and is more indicative of the rheological properties of the 
polymers.  The polydispersity index (PDI) is the ratio of the Mw to the Mn.  For a polymer 
of perfectly uniform molecular weight distribution, this ratio is 1.000, but is usually 
higher.   
Inherent Viscosity (IV) 
The IV in a dilute solution was determined using a Cannon Fenske Routine U-
Tube Viscometer (CFRC Series) immersed in a water bath maintained at a temperature of 
25°C.  A volume of 10mL of a pure solvent, either chloroform (CHCl3) or hexafluoro-2-
propanol (HFIP),  was loaded into the viscometer and allowed to thermally equilibrate to 
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the bath temperature for at least 7 minutes.  Solvent retention time was measured using a 
stopwatch.  A 25mg sample was then dissolved in that same solvent at a concentration of 
1mg/mL.  The relationship of these two retention times was then used to determine the IV 
of the polymer in that solvent.   
Stress-Strain Fiber Mechanical Testing 
The mechanical properties of the fiber were determined at room temperature 
using a MiniBionix Universal Tester (MTS), Model 858, equipped with a 1 kN load cell.  
Fiber samples were secured in grips that were initially 70mm apart and then strained at a 
constant rate of 1 mm/s, following USP 31 standardized methods for testing fibers [4].  
Using these methods, the stress at failure was determined for both knotted and unknotted 
fibers to determine the untied (straight) ultimate tensile strength (UTS) as well as the 
knotted ultimate tensile strength (Knotted UTS).  A measurement of fiber stiffness, the 
Young’s modulus, was also found.  The  Young’s modulus (modulus) is defined as the 
stress-strain slope of the tensile curve from zero elongation to the point of yielding.   
The UTS for a straight fiber reveals the maximum strength properties of the 
material, but the knot UTS indicates how high a load the fiber can support when knotted 
as it would be during use.  An annotated stress-strain curve similar to that used in the 





               Figure 2.  MTS Fiber Tensile Testing Setup 
 
 
In vivo and in vitro Breaking Strength Retention (BSR) 
Percent in vitro breaking strength retention (BSR) was measured by testing the 
ultimate tensile strength using the previously described method, before and after 
incubation for predetermined time periods in a 7.4 pH phosphate buffer at known 
temperatures.   
In order to determine the percent in vivo BSR, sutures purified by devolatilization 
were sterilized by ethylene oxide.  Ethylene oxide sterilized sutures approximately 27 cm 
in length were implanted above the legs of Spraque Dawley rats samples were tested 
using the stress-strain method described above.  Identical samples were subcutaneously 
implanted in Sprague-Dawley rats for extended periods of time, then tested using the 
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same stress-strain method described above.  The results were compared to the pre-
implantation results to determine in vivo BSR. 
 
                          Figure 3.  Rat Implant Sites for BSR 
 
Assessment of Suture Swelling Properties 
Each suture was cut into 6-inch pieces and secured in a loop fashion using a 
clamp.  This loop was submersed in 0.1M phosphate buffer with 0.2 wt. % Tween 20 as a 
detergent, which was added to accelerate water uptake, allowing for fast comparative 
results.  The portion of the loop opposite the clamp was observed using a Leica optical 
microscope before and after submersion for a controlled amount of time.  The purpose of 
the loop was to assure that the fiber was in same axial orientation before and after testing, 
since the fibers were not completely cylindrical. 
In vitro Absorption Assessment 
 Percent in vitro mass loss, a predictive measure for in vivo absorption rate, was 
measured by weighing dry samples of the polymer before and after incubation for 
predetermined time periods in a 7.4 pH phosphate buffer at known temperatures, with the 




In vivo Absorption Assessment 
 In order to evaluate and compare the absorption and tissue reaction of each suture 
material, ethylene oxide sterilized (ETO) test suture materials were implanted 
subcutaneously in the gluteal muscle of Sprague Dawley rats.  This method was approved 
by The Clemson University Institutional Animal Care and Use Committee (IACUC).  
The rats were maintained by the Godley-Snell Research Center  at Clemson University 
for pre-determined lengths of time, at which point the rats were humanely euthanized 
with carbon dioxide gas.  Following euthanization, the rats were perfused using 
glutaraldehyde.  The gluteal muscles were explanted and stored in 10% formalin, until 
being sectioned and processed into microslides using hematoxylin and eosin staining.  
 Reactive changes were then assigned a severity score by a licensed 
histopathologist (1=minimal, 2=mild, 3=moderate, and 4=severe), who evaluated an 
scored observable tissue reaction.   
Statistical Analysis 
 Statistical analysis was performed selectively on groups of particular interest in 
this study to determine the significance of the data.  Due to large differences in variance, 
the particular method used was an independent two-samples t-test for unequal sample 
sizes with unequal variance (Welch’s t-test).  Sample standard deviations are combined, 
if necessary by calculating the square root of the sum of squared standard deviations 
being added.  Standard deviations (s), sample number (n), and the sample average X are 
necessary for this calculation.  The number of degrees of freedom (d.f.) and the t statistic 




t= X1-X2sX1-X2 where X1-X2=Difference in Sample Averages, SX1-X2=
 s1
2
n1   - s2
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RESULTS AND DISCUSSION 
Development of 1,4 Dioxan-2-one-Based Candidates for Fiber Formation 
 Polymer compositions for an initial group of l-lactide based polymers, initiated by 
PEG 20,000 using an identical monomer:catalyst molar ratio (M/C), are summarized in 
Table 4.   





















8% 0% - 92% 
Lac/Gly 
(94/6,mol) 2 





LAC4 1 9% 9% 82% 
LAC5 1 23% 2% TMC 75% 
A
All lots had an M/C = 3000 and were initiated by PEG 20,000 kg/mol 
B
 Lac=l-lactide, ε-Cap= ε-caprolactone, TMC=trimethylene carbonate,    
   Gly=glycolide 
 
 
The molecular weight of the polymer was determined using GPC, with methylene 
chloride as the solvent (DCM, CH2Cl2).  In addition, the rheological behavior of the 
polymer and the melt-extruded pre-fibrous form of this polymer were evaluated by 
determining the inherent viscosity (IV), with methane trichloride as the solvent 
(chloroform, CHCl3).  These analyzed properties are given, along with the weight percent 
l-lactide (% lactide) and weight percent PEG (% PEG) for each polymer in Table 5.   
 Tensile properties of the fibers, as determined using the MTS tensile testing machine, are  
 




 Table 5.  Polymer Properties for PEG20K-Initiated L-Lactide-Based    
Polymers
A
 (n=1 for DSC, GPC, I.V.) 
Lot Information
 



























































































14.9 0.97 - 
 A 
MW = molecular weight, MW Def . = molecular weight definition, Mn = number    
  average MW, Mw = weighted average MW, Mp = peak value MW, PDI = polydispersity  
 index (ratio of Mw to Mn), DV I.V. = Inherent Viscosity of  Devolatilized Polymer, Ext.  
 I.V. = Inherent Viscosity of Extruded Polymer  
B
Diam. = fiber diameter, M =  
 Young’s modulus, % Elong = strain at failure 
 




















Diam., mm Mod., % Elong 
Strength, MPa 
UTS Knot UTS 
Avg±Std Avg±Std Avg±Std Avg±Std Avg±Std 
LAC1 1 0.37 ± 0.0 4.3 ± 0.3 54 ± 7.6 379 ± 39 255 ± 20 
LAC2 
1 
0.60 ± 0.0 3.3 ± 0.1 67 ± 5.3 365 ± 21 221 ± 19 
0.39 ± 0.0 4.5 ± 0.1 47 ± 3.5 483 ± 48 310 ± 32 
2 
0.38 ± 0.0 4.3 ± 0.4 43 ± 8.3 345 ± 37 276 ± 21 
0.24 ± 0.0 4.4 ± 0.4 45 ± 1.9 365 ± 18 255 ± 18 
LAC3 1 0.10 ± 0.0 3.0 ± 0.5 93 ± 7.7 372 ± 5 359 ± 5 
LAC4 1 0.37 ± 0.0 2.7 ± 0.2 59 ± 1.6 317 ± 2 241 ± 2 
LAC5 1 0.25 ± 0.0 2.3 ± 0.1 87 ± 5.9 221 ± 2 214 ± 1 
                     A
Diam.=Diameter, Mod.=Modulus, %Elong=%Elongation, 
                Avg=Average, Std=Standard Deviation 
 
           Table 6b.  Sample Means and Standard Deviations for Modulus and UTS
 
Name 
Mean Modulus ± 
Standard Deviation (n) 
Mean UTS ± Standard 
Deviation (n) 





390±67 MPa (n=20) 
LAC3 4.5±0.5 (n=5) 372±5 MPa (n=5) 
LAC4 4.3±0.2 (n=5) 317±2 MPa (n=5) 
LAC5 4.4±0.1 (n=5) 221±2 MPa (n=5) 
           
 Swellable polymers, as discussed in this study, are a system of polymers that is 
unique due to the presence of both a hydrophilic component and a hydrophobic 
component (amphiphilic).  The hydrophilic component comprised either polyethylene 
glycol with a molecular weight of 20,000 g/mol (PEG 20K) or polyethylene glycol with a 
molecular weight of 35,000 g/mol (PEG 35K).  The hydrophobic component consisted of 
l-lactide, glycolide, TMC, or ε-caprolactone.  The effects of fiber composition on fiber 
properties was investigated.  Correlations of relationships affecting these properties are 





Figure 4a.  Effects of PEG on Strength 
 
 
Figure 4b.  Effects of Lactide on Strength 
 
 




Figure 4d.  Effects of Lactide on Young’s 
Modulus 
 Figures 4a-4d.  Tensile Effects of Wt. % PEG 20K (%PEG) and Wt. % l-lactide   





Figure 5a.  Ability of Mn, Mw, and Mp     
                   (GPC) to Predict Strength 
 
Figure 5b.  Ability of Inherent Viscosity to      
        Predict Fiber Strength 
Figures 5a-5b.  Correlation of Molecular Weight Definitions and IV to Predict UTS  
  
 As demonstrated in Figure 3a, % PEG is more useful in predicting the expected 
UTS of the fiber, with a better correlation coefficient (R
2
) of 0.75.  It is less useful in 
predicting the Knot UTS, with the best R
2 
value available using fitted equations only 
being 0.21.  Figure 3b shows that %Lactide has a lower correlation than % PEG for UTS 
and knot UTS.  Neither one shows a strong correlation.  PEG and % Lactide showed 
equal potential to predict Young’s Modulus with an R
2 
values of 0.52 (Figures 3d and 3f). 
The best predictors of UTS were actually those requiring the least operator 
attention to detail and the least time-on-task, namely, the GPC measurements Mn and Mp 
(R
2
=0.81 and 0.75 respectively).  Contrary to previous beliefs, as demonstrated in Figure 
4b, the IV for the melt extruded polymer was not useful in predicting UTS (R
2
=0.08).  
The IV for the devolatilized polymer was a better predictor (R
2
=0.66). 
As expected based on the %PEG and %Lactide, the highest average UTS values 
were observed for LAC1 and LAC2, polymers with average values that are very close.  
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The calculated values for d.f. and the t-value are calculated using equations 1 and 2     
(d.f. =10.84 and t-value = -1.232).   A 2-tailed Welch’s t-test was performed, with the 
null hypothesis being that the strengths are equal.   The resulting P value is 0.25, which is 
much greater than 0.05, therefore the null cannot rejected.  Therefore, based on this 
calculation, LAC1 and LAC2 may have the same strength.    
While high UTS and knot UTS values are desirable, it is preferred that the 
Young’s modulus be lower to improve the “hand” of the fiber (an industry term 
describing the ease of handling and knot characteristics of a suture).  LAC3 and LAC4 
both show potential based on their % PEG content and apparent high fiber strengths, 
coupled with lower moduli.  LAC5, while expected to uptake the largest amount of water 
(and therefore swell the most) has an expectedly low UTS and knot UTS.   
Polymer synthesized with the higher molecular weight initiator was expected to 
allow an Mn that was higher for a given %PEG than that of PEG20K.  The compositions 
for these polymers are given in Table 7.  The corresponding properties of these polymers 
are given in Tables 8a, 8b, and 8c.   
Table 7.  Compositions for PEG35K-Initiated Polymers 









































            A
All lots had an M/C = 3000 and were initiated by PEG 20,000 kg/mol 
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     Table 8a.  Polymer and Fiber Properties for PEG35K-Initiated  
                Polymers/Fibers
A
 (n=1 for DSC, GPC, I.V.) 
Lot Information
 























































































MW = molecular weight, MW Def . = molecular weight definition, Mn = 
number average MW, Mw = weighted average MW, Mp = peak value MW, DV 
I.V. = Inherent Viscosity of Devolatilized Polymer  
 
Table 8b.  Polymer and Fiber Properties for PEG35K-Initiated Polymers/Fibers (n=5) 
Name and 
Lot 
Diam., mm Mod., % Elong 
Strength, MPa 
UTS Knot UTS 
Avg±Std Avg±Std Avg±Std Avg±Std Avg±Std 
LAC6 
1 
0.22 ± 0.00 3.3 ± 0.1 58 ± 5.3 409 ± 26 293 ± 7 
0.31 ± 0.00 3.2 ± 0.1 60 ± 2.7 427 ± 9 274 ± 23 
2 0.40 ± 0.03 3.3 ± 0.4 57 ± 3.1 389 ± 68 261 ± 12 
3 
0.33 ± 0.02 2.9 ± 0.3 64 ± 5.5 406 ± 23 269 ± 28 
0.37 ± 0.01 3.3 ± 0.1 57 ± 2.6 488 ± 32 267 ± 28 
LAC7 
1 0.28 ± 0.00 1.8 ± 0.1 99 ± 8.5 312 ± 7 288 ± 6 
3 0.38 ± 0.02 2.5 ± 0.2 81 ± 5.5 296 ± 21 259 ± 21 
5 0.47 ± 0.02 2.6 ± 0.2 69 ± 9.1 270 ± 23 232 ± 12 
LAC8 1 0.24 ± 0.01 0.9 ± 0.0 
15
7 
± 9.7 214 ± 8 213 ± 25 
A
Diam.=Diameter, Mod.=Modulus, %Elong=%Elongation, Avg=Average, Std=Standard  








Mean Modulus ±  
Standard Deviation (n) 
Mean UTS ± Standard 
Deviation (n) 
Mean Knot UTS ± 
Standard Deviation (n) 






LAC8 0.9±0.03 (n=5) 214±8 (n=5) 213±25 (n=5) 
 
 
The resultant fiber properties of the fibers composed of LAC6, LAC7, and LAC8 
are comparable to those of LAC1-LAC5, and allow the utilization of PEG content that is 
at least 6% higher than that of any of the previously specified PEG20K-initiated 
polymers of acceptable strength.  LAC8 has strength that is lower than desired.  LAC6 
has the highest UTS of the three polymers, but the Knot UTS for this fiber is nearly 
equivalent to the proven repeatable knot UTS of LAC7.  This can be demonstrated with a 
two tailed Welch’s t-test analysis of LAC6 vs. LAC7, which results in a p-values of 
0.075.  Therefore, with alpha set to 0.05, there is not necessarily a difference between the 
knot strengths for LAC6 and LAC7.  A t-test on LAC7 vs. LAC8, however, demonstrates 
that there is a very low p-value between these two polymers (p-value=0.002).  Therefore, 
it can be determined that there is a difference in knot strength between these two 
polymers.   
In order to make a final determination about the relative suitabilities of LAC6 and 
7 as swellable fiber candidates, the in vitro BSR, the swelling capability, and the mass 





    Table 9.  Break Strength Retention for LAC6 and LAC7  (n=4) 
Lot Information 
Break Strength Retention (BSR) 
Fiber Tensile Data
A








1 2 3 
LAC6 
1 
0.31±0.00 427±9 82±3.7 78±1.0 71±4.5 
0.22±0.00 409±26 80±2.9 75±1.1 72±1.6 
0.13±0.00 487±12 87±10.2 82±0.8 76±1.6 
2 0.19±0.01 455±47 78±9.0 74±1.2 - 
3 
0.31±0.00 406±50 78±5.6 - - 
0.36±0.02 324±35 - 72±1.0 - 
0.48±0.00 296±27 - 79±1.3 - 


























0.28±0.00 312±7 69±20.1 57±2.3 50±0.5 
0.22±0.01 299±30 70±17.8 57±0.5 - 





0.38±0.02 296±21 85±5.1 68±2.7 - 
0.43±0.00 303±9 62±2.9 52±1.3 - 









    A 
Diam. = fiber diameter, N/A = Not Applicable 
 
              Table 10.  Simulated Physiological Condition Swelling in vitro 
                             (0.1M/7.4 pH/37°C Phosphate Buffer) 
Name % PEG PEG MW Diameter, mm ∆CA in 1 Hr
A 
LAC6 15 PEG35K 0.13 10.5±1.1% 
LAC6 15 PEG35K 0.19 6.9±1.0% 
LAC6 15 PEG35K 0.22 1.8±3.3% 
LAC6 15 PEG35K 0.36 5.5±0.3% 
LAC7 20 PEG35K 0.28 13.5 ± 1.6% 
LAC7 20 PEG35K 0.29 4.6 ± 0.3% 
LAC7 20 PEG35K 0.29 6.41±3.10% 
LAC7 20 PEG35K 0.38 6.05 ± 0.92 
LAC8 25 PEG35K 0.28 65.7 ± 1.0% 
     
A




Table 11.  Simulated Physiological Condition Mass Loss in vitro (0.1M/7.4 pH/37°C   
                  Phosphate Buffer) 
LAC6 - 7.4 pH/37°C 
 
Time 






4 Month 7.5±0.6 7.4±1.2 
12 Month 58.3±1.9 37.1±1.4 
15 Month 64.8±5.7 52.3±6.4 
      LAC7 - 7.4 pH/37°C 
 
Time 








4 Month 15.2±0.2 18.8±1.2 13.0±0.8 
6 Month - 25.5±1.9 21.4±0.7 
12 Month 67.9±9.7 83.0±5.9 51.5±4.6 
15 Month 55.8±3.7 - - 
 
 
While the BSR for LAC6 is longer than the BSR for LAC7, the swelling 
capability is less than that of LAC7.  Also, given the increased time period necessary to 
fully absorb LAC6, of the l-lactide-based fibers evaluated, LAC7 appears to be the best 
candidate for a long-lasting fiber. 
Assessment of 1,4 Dioxan-2-one-Based Fibers 
 In order to investigate an alternate polymer system to the l-lactide-based polymer 
system, a separate polymer system based on 1,4-Dioxan-2-one (PDO) was investigated.  
This polymer system was expected to have a BSR profile more closely aligned with full 
absorption and is also closer in composition to PDS-II, a commercially available 
monofilament suture in prevalent use.  This family of PDO-based polymers was 
catalyzed with an M/C equal to 5000 and initiated by either polyethylene glycol with a 






            Table 12.  Compositions for PEG-Initiated PDO-Based Polymers 





























All lots had an M/C = 3000 and were initiated by PEG 20,000 kg/mol 
 
 
GPC was not possible, due to the polymer family insolubility in methylene 
chloride (DCM), so molecular weight properties of the polymer and the melt-extruded 
pre-fibrous form of these polymers were evaluated by determining the inherent viscosity 
(I.V.), with hexafluoro-2-propanol (HFIP) as the solvent.  Tensile properties of the fibers 
were determined with MTS.  These analyzed properties are given, along with the weight 
percent PDO (%PDO) and weight percent PEG (% PEG) for each polymer in Tables 13a 
and 13b.   
Tensile properties of the PDO fibers, as determined using the MTS tensile testing 
machine, are given in Tables 13a and 13b.  The knotted and unknotted strengths of the 
fibers were determined in a fashion identical to that used for the lactide based polymers.  
In addition, the Young’s modulus and the amount of strain realized before failure of the 
suture was also determined.  The stress-strain curve is nearly identical in shape to that of 
the l-lactide based polymers.  The corresponding properties for these polymers are given 




Table 13a.  Polymer and Fiber Properties for PEG20K-Initiated PDO- 









































































Table 13b.  Polymer and Fiber Properties for PEG20K-Initiated PDO-Based     






Diam., mm Mod., % Elong 
Strength, MPa 
UTS Knot UTS 




0.20 ± 0.00 2.2 ± 0.2 46 ± 3.2 510 ± 38 426 ± 32 
0.30 ± 0.02 1.3 ± 0.2 54 ± 5.7 432 ± 40 290 ± 27 
0.46 ± 0.02 0.7 ± 0.1 69 ± 3.9 339 ± 32 231 ± 23 
3 
0.21 ± 0.00 1.3 ± 0.1 51 ± 2.2 485 ± 27 349 ± 29 
0.25 ± 0.01 2.3 ± 0.1 45 ± 2.4 592 ± 20 462 ± 34 
PDO
2 
1 0.33 ± 0.01 1.1 ± 0.0 54 ± 1.5 472 ± 19 216 ± 21 
2 0.10 ± 0.01 1.5 ± 0.2 67 ± 12 834 ± 85 560 ± 46 
3 
0.32 ± 0.01 1.5 ± 0.1 44 ± 3 451 ± 37 NA 
0.54 ± 0.05 1.0 ± 0.1 51 ± 3.3 358 ± 51 206 ± 17 
4 
0.11 ± 0.01 0.6 ± 0.2 171 ± 63.3 298 ± 63 325 ± 50 
0.21 ± 0.01 0.7 ± 0.0 63 ± 9.5 440 ± 32 296 ± 26 
0.34 ± 0.01 1.1 ± 0.1 58 ± 10.4 476 ± 27 253 ± 15 
PDO
3 









0.19 ± 0.01 2.3 ± 0.2 49 ± 5.1 621 ± 34 372 ± 31 
0.34 ± 0.01 2.3 ± 0.1 46 ± 4.7 640 ± 37 385 ± 19 
                   A
Diam.=Diameter, Mod.=Modulus, %Elong=%Elongation, Avg=Average, Std=Standard    
               Deviation, NA = Not Available 
 
 
The PDO DV increased with increased design molecular weight; however, the 
resulting strength of the fiber was not affected in a predictable manner.  This result is 
somewhat counterintuitive.  Weight percentage of PEG and weight percentage of PDO 
had no effect on strength either.  Crystallinity only slightly decreased as the weight 
percentage of PEG increased (as the weight percentage of PDO decreases), but it should 
be noted that the weight percentage of PEG was only varied between 4-8%.  These 





Figure 6a.  Effects of PEG on Strength 
 
Figure 6b.  Effects of Design  
MW on Strength 
 
            Figure 6c.  Effects of PEG on Crystallinity (∆H) 






















Table 14.  Break Strength Retention for PDO1-4 
Lot 
Information 













2 3 4 6 
PDO1 
1 
0.30±0.02 62.6±5.8 76.2±12.2 68.8±16.0 - - 
0.46±0.02 49.2±4.6 79.7±2.7 75.0±2.4 - - 
0.492±0.02 37.2±3.8 92.1±10.0 83.7±15.7 - - 
3 
0.24±0.00 
94.0±0.3 61.9±0.16 - 34.8±1.9 - 













0.33±0.00 51.9±7.4 35.6±2.4 - 16.2±9.8 12.2±9.0 
0.30±0.01 74.5±1.7 46.8±23.5 - 39.1±4.4 26.9±1.2 
3 
0.54±0.05 80.8±2.6 84.0±3.7 - 41.6±15.3 17.5±14.0 
0.32±0.01 65.4±5.4 86.0±4.2 - 27.6±9.5 15.7±0.7 
4 
0.21±0.01 63.8±4.7 68.7±10.1 - 65.0±8.0 21.2±11.2 
0.34±0.09 54.8±3.9 88.0±1.0 - 51.0±13.6 38.1±3.2 











PDO3 1 0.37±0.01 43.0±3.3 73.9±2.7 - 60.5±1.8 43.6±2.4 












0.19±0.01 90.0±4.9 64.4±11.6 - 35.9±12.7 14.0±5.1 
0.34±0.00 79.9±3.9 83.5±1.5 - 59.6±8.4 24.6±12.8 

























                         Table 15.  Simulated Physiological Condition Swelling in vitro   
       (0.1M/7.4 pH/37°C Phosphate Buffer) 
Name % PEG PEG Diam, ∆CA
A 
PDO4 6 PEG14K 0.19 8.4 ± 1.8 
PDO4 6 PEG20K 0.34 9.5 ± 1.4 
PDO2 6 PEG20K 0.11 11.0 ± 
PDO2 6 PEG20K 0.21 6.9 ± 1.34 
PDO2 6 PEG20K 0.32 5.8 ± 2.31 
PDO2 6 PEG20K 0.33 8.1 ± 2.2 
PDO2 6 PEG20K 0.36 7.1 ± 1.80 
PDO2 6 PEG20K 0.43 5.3 ± 1.58 
PDO2 6 PEG20K 0.54/ 5.7 ± 1.46 
                                       A
% Change in Cross-Sectional Area 
 
    Table 16.  Simulated Physiological Condition Mass Loss in vitro          
                      (0.1M/7.4 pH/37°C Phosphate Buffer) 




1.4 Month (6 Week) 22.3 ± 1.4 5.4 ± 0.4 
1.8 Month (8 Week) 34.1 ± 1.6 7.3 ± 0.1 
4.0 Month (17.4 Week) 73.1 ± 5.7 - 
5.1 Month (22 Week) - 84.6 ± 1.8 
 
While the % BSR for PDO2 and PDO4 do not appear to be different, the average 
initial strength of PDO4 22N higher.  This suggests, therefore, that the PDO4 fiber was 
stronger at the same time-point.  Additionally, given limited data, it appears that the 
cross-sectional area changes in vitro for PDO4 were at least as high as those for PDO2.  It 
actually appears that for this system of fibers, fiber strength decreased with increased 
theoretical molecular weight and that PDO4 actually had comparable strength to that of 
PDS-II®.   
 Additionally, the in vitro mass loss rates for both fibers are very comparable to 
those of PDS-II, as presented in the product packaging.  Despite the shortcomings of 
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PDO2 relative to PDO4, PDO2 was tested more extensively because it was perceived to 
be the better candidate at the time. 
Assessment of Primary Candidates for a Swellable Fiber  
 LAC7, PDO2, and PDO4 were all chosen as potential candidate polymers for 
processing into absorbable, swellable sutures due to their favorable properties relative to 
the other polymers with similar compositions.  Low modulus, high strength (particularly 
knot strength), and an ability to maintain strength for a longer timeframe are all desirable 
properties, while a low rate of mass loss is undesirable. 
 Fiber properties can change during ethylene oxide sterilization.  When sterilizing 
absorbable, synthetic polymers, it is common for the moduli to decrease, thereby 
improving the hand of a fiber, but also decreasing the strength.   In addition, the 
elongation often increases.  The simultaneous occurrence of increased elongation and 
decreased modulus allows the material to maintain more of its toughness, an engineering 
definition corresponding to the amount of energy a material can absorb without fracture.    
 The fiber properties before and after sterilization are shown in Table 16.  This 
table also shows the percent changes for the modulus, elongation, and strengths.  LAC7 
and PDO2 fibers with corresponding diameters are shaded in gray.  The average values 
for several of the parameters listed in Table 17 are given in Table 18, in order to 
quantitatively compare these properties. 
 Parameters used to assess polymer behavior under various conditions, but which 
are not important to the final mechanical properties are percent change in modulus, 
percent change in elongation, and percent change in strength.  It is noticed that EtO 
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treatment of PDO2 tended to increase modulus, while EtO-treated LAC7 became softer.  
Percent elongation at failure increased, for both fibers, with EtO treatment, but 14% more 
for EtO-treated LAC7. The average strength, both knot UTS and UTS, decreased for both 
fiber types with EtO treatment.  This result is likely due to presence of moisture in the 
sterilization process at elevated temperature.  It is believed that PEG content of the 
polymers is conducive to water absorption, and therefore decreased the molecular weight 
by chain cleavage during sterilization. 
 Sterilized PDO4 has a higher UTS, higher Knot UTS, and lower Modulus than 
sterilized LAC7, which can be seen in Table 16.  The modulus was drastically lowered by 
sterilization, presumably due to relaxation of the fiber.  This decrease is likely due to 
greater mobility in the chains as well as the lower glass transition temperature of PDO.  It 
should be noted that the single lot of PDO that was sterilized had tensile properties that 




















Fiber Tensile Properties 
Modulus (M), % Elongation (E), Strength (S) and  
Changes of These Properties (∆) Due to the  
Ethylene Oxide Sterilization Technique Used 
M, 
MPa 
∆M E, % 
∆E, 
% 


















After 0.19 3.0 71 427 303 






After 0.22 2.2 109 296 269 






After 0.3 1.8 118 241 228 






After 0.31 2.1 95 331 262 






After 0.39 2.2 102 207 - 


















After 0.21 0.7 62 414 303 






After 0.24 0.9 186 200 179 






After 0.28 1.3 147 248 207 






After 0.33 1.5 46 372 241 


















After 0.35 0.8 64.8 592 361 
 
A
Shaded lines for LAC7 and PDO2 represent fibers with fibers of the other polymer of 
corresponding diameters of 0.22, 0.29, 0.30, and 0.45, referenced in the Table 17. 
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Averaged Fiber Tensile Properties 
Modulus (M), % Elongation (E), Strength (S) and  
Changes of These Properties (∆) due to the  
Ethylene-Oxide Sterilization Technique Used 
M, 
ksi 
∆M E, % ∆E, % 












0.21 2.2 7% 109 28% 296 269 -6% -15% 
0.28 1.8 0% 118 19% 241 228 -23% -18% 
0.29 2.1 -11% 95 15% 331 262 -17% -6% 


























0.21 2.2 8.0% 62 -2% 414 303 -5% -15% 
0.28 1.8 22.0% 147 8% 248 207 0% -8% 
0.32 2.1 -1.0% 46 4% 372 241 -17% -25% 























  Table 19 compares the in vitro and in vivo BSR values for sterilized fibers.  It is 
apparent from the data that the in vitro methods used for predicting BSR produce data 
that is very similar to the data produced by implantation in rats.  In vivo conditions cause 
quicker strength loss than in vitro, likely due to enzymatic influences in the body that are 
not present in the buffer.  PDO4, which starts out with the highest of initial strengths of 
the three candidate sutures, also maintains strength the longest.  In fact, the in vivo BSR 





     Table 19.  Break Strength Retention of Fibers in vitro (ivt) & in vivo (ivv)  













% BSR / (UTS, MPa) 
2 Wk. 





0.33±0.02 35.1±2.4 Ivt 74 ± 4.7 48 ± 1.8 25 ± 1.5 
0.39±0.03 30.4±1.7 Ivv
B 
55 ± 6.0 42 ± 5.1 30 ± 3.8 
0.38±0.02 42.9±3.1 Ivt 47 ± 2.7 35 ± 0.7 24 ± 1.1 
0.38±0.01 46.9±2.4 Ivv
C
 42 ± 2.5 30 ± 4.0 20 ± 4.1 
0.44±0.02 44.0±2.7 Ivt 86 ± 1.6 28 ± 1.2 16 ± 2.4 
0.46±0.03 42.5±4.1 Ivv
D






0.32±0.01 65.4±5.4 Ivt 89 ± 6.1 62 ± 11.4 28 ± 1.0 
0.33±0.02 54.2±4.5 Ivv
E
 70 ± 2.0 51 ± 5.0   - 
0.42±0.01 63.2±2.4 Ivt 93 ± 23. 80 ± 4.4 51. ± 1.2 
0.42±0.01 63.2±2.4 Ivv
F





 0.34±0.00 79.9±3.9 Ivt 55 ± 4.7 42 ± 8.8 30 ± 13.
0.35±0.00 85.9±4.7 Ivv
G







0.33±0.01 80.5±2.1 ivv 93 ±  80 ±     
        A
Diam.=Fiber Diameter, Wk. = Weeks, 
B
Rat #’s 725/727/726 for 2/4/6 Week     
       Respectively, 
C
Rat #’s 687/691/692 for 2/4/6 Week Respectively, 
D
Rat #’s   
       683/684/685 for 2/4/6 Week Respectively, 
E
Rat #’s 681/684/682 for 2/4/6 Week  
       Respectively, 
F
Rat #’s Not Available, 
G
Rat #’s 702/703/704 for 2/4/6 Week  
       Respectively 
 
 
 After implanting sutures in Sprague Dawley Rats for up to 9 months, an American 
College of Veterinary Pathologists Board-certified pathologist with experience in 
determining the irritation potential of biomaterials examined these explanted samples 
without any knowledge of the structural of chemical composition of the sutures, rating 
each specimen for indicators of reactive changes on a scale of 1-4 (1 = minimal, 2 = mild, 
3 = moderate, and 4 = severe).  The specific indicators assessed were polymorphonuclear 
neutrophils (PMNs), macrophages, lymphocytes, giant cells, fibrosis, and necrosis.       
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 Table 20 summarizes the histological findings for microscopic histological 
samples derived from sutures implanted intramuscularly in the gluteal muscles of 
Sprague Dawley rats.  The sum of the individual pathology severity scores for each 
suture was indicative of the overall biocompatibility of that suture when implanted 
intramuscularly.  Figures 7, 8, and 9 show explanted histological samples used for these 
determinations.  PDO2 showed a high level of reactivity after 3 months, but this was very 
likely due to very rapid degradation occurring at this time, resulting in no suture being 
present after only 4 months.  LAC7, on the other hand, was still present in considerable 





























 Table 20. Histological Rankings for Sutures Implanted in the Gluteal Muscle of Sprague     























































































































































USP Suture Diameter 



































































































































PMN’s 1 0 0 0 0 - 0 0 0 0 0 
Macrophages 2 1 2 0 3 - 0 0 0 0 0 
Lymphocytes 1 1 0 0 1 - 0 0 0 0 0 
Giant Cells 0 0 0 0 0 - 0 0 0 0 0 
Fibrosis 2 1 1 1 2 - 2 1 1 1 2 
Necrosis 0 0 0 0 0 - 0 0 0 0 0 
Combined Score 6 3 3 1 6 A 2 1 1 1 1 
  A





PDO2 1 Week 
 
(Initial Diameter = 0.32 mm) 
LAC7 1 Week 
(Initial Diameter = 0.22 mm) 
Monocryl 1 Week 
 
(Initial Diameter = 0.37 mm) 





















PDO2 3 Month 
 
(Initial Diameter = 0.43 mm) 
LAC7 4 Month 
(Initial Diameter = 0.38 mm) 





6 Month  (Initial Diameter = 0.21 mm) 
LAC7 6 Months
 
6 Month  (Initial Diameter = 0.21 mm) 
LAC7 9 Months 
 
9 Month  (Initial Diameter = 0.21 mm) 










Lactide/PEG-based hydroswellable polymers initiated by polyethylene glycol 
(less than or equal to 35,000 g/mol) are not good candidates for swellable sutures because 
the addition of enough polyethylene glycol to more than a 10% change in cross-section 
results in unacceptable strength decreases.  In addition, even after 9 months in vivo, 
LAC7 was did not appear to degrade at a rate fast enough to allow full absorption in less 
than a year.    
The PDO-based polymers tested in this study are the better candidates for further 
optimization because of their strength and their ability to absorb quickly relative to the 
















 Efforts to improve the PDO system polymers may be quite successful, given the 
single lot strength and BSR similarity of PDO 4 to that of PDSII, coupled with its proven 
ability to swell in an aqueous environment while also absorbing completely in a 
simulated physiologic environment within 4 months.  A method for determining swelling 
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